Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-04-16 Purchase |
2021-04-20 9:30 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Lux Ventures IV L.P. Lux Co-Invest Opportunities L.P. Lux Co-Invest Partners LLC Lux Venture Partners IV LLC 10% Owner |
100,000 | $18 | $1,800,000 | 17,287,095 (Indirect) |
View |
| 2021-04-16 Purchase |
2021-04-20 5:06 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
2,777,777 | $18 | $49,999,986 | 8,740,917 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-20 Conversion |
2021-04-20 9:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Lux Ventures IV L.P. Lux Co-Invest Opportunities L.P. Lux Co-Invest Partners LLC Lux Venture Partners IV LLC 10% Owner |
51,536,283 | $0 | 17,287,095 (Indirect) |
View |
Ownership |
2021-04-20 5:07 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | MIC CAPITAL PARTNERS (PUBLIC) (US) IM LLC 10% Owner |
0 | $0 | 1,388,889 (Indirect) |
View |
| 2021-04-20 Conversion |
2021-04-20 5:06 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
15,333,484 | $0 | 8,740,917 (Indirect) |
View |
| 2021-04-15 Option Award |
2021-04-19 7:28 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
41,667 | $0 | 3,846,216 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 7:27 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director |
18,750 | $0 | 543,750 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 7:25 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
18,750 | $0 | 543,750 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 7:23 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
18,750 | $0 | 543,749 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 7:21 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
18,750 | $0 | 7,700,856 (Direct) |
View |
Ownership |
2021-04-15 3:49 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
0 | $0 | 13,026,009 (Indirect) |
View |
Ownership |
2021-04-15 3:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Data Collective IV L.P. Data Collective IV GP LLC DCVC V GP LLC DCVC V L.P. DCVC Opportunity Fund II GP LLC DCVC Opportunity Fund II L.P. Ocko Matthew 10% Owner |
0 | $0 | 13,619,224 (Indirect) |
View |
Ownership |
2021-04-15 3:43 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Bogue Zachary Director 10% Owner |
0 | $0 | 13,619,224 (Indirect) |
View |
Ownership |
2021-04-15 2:18 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Lux Ventures IV L.P. Lux Co-Invest Opportunities L.P. Lux Co-Invest Partners LLC Lux Venture Partners IV LLC 10% Owner |
0 | $0 | 17,187,095 (Direct) |
View |
Ownership |
2021-04-15 09:03 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Corp. Dev. Officer |
0 | $0 | 750,000 (Direct) |
View |
Ownership |
2021-04-15 09:02 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
0 | $0 | 2,849,075 (Direct) |
View |
Ownership |
2021-04-15 09:01 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
0 | $0 | 3,804,549 (Direct) |
View |
Ownership |
2021-04-15 08:59 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
0 | $0 | 915,000 (Direct) |
View |
Ownership |
2021-04-15 08:58 am |
N/A 2030-03-19 |
RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director |
0 | $0 | 525,000 (Direct) |
View |
Ownership |
2021-04-15 08:57 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer 10% Owner |
0 | $0 | 10,967,883 (Direct) |
View |
Ownership |
2021-04-15 08:56 am |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
0 | $0 | 750,000 (Direct) |
View |
Ownership |
2021-04-15 08:55 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-04-15 08:54 am |
N/A 2030-04-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
0 | $0 | 525,000 (Direct) |
View |
Ownership |
2021-04-15 08:53 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
0 | $0 | 524,999 (Direct) |
View |
Ownership |
2021-04-15 08:53 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
0 | $0 | 7,682,106 (Direct) |
View |